Pre-Clinical Study Evaluating Novel Protein Phosphatase 2A Activators as Therapeutics for Neuroblastoma.

Cancers (Basel) · 2022 · PMC9026148 · PMID 35454859

Europe PMC DOI

hedged sentence

0.0570

closest p · 1.1× alpha

0.0570

boldest claim

The sentences

did not reach statistical significancep = 0.057so close (0.05 < p ≤ 0.1)

Tumors from animals treated with 1154 tended to have increased necrosis but did not reach statistical significance compared to those from vehicle treated animals ( Figure 6 C, p = 0.057, right panel ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.